Capillary electrophoresis fragment analysis and clone sequencing in detection of dynamic mutations of spinocerebellar ataxia

Y CHEN, Y HAO, J ZHANG, X ZHANG, K XIE… - Chin J Contemp Neurol …, 2018 - cjcnn.org
… The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies[J].
J … kinase(CK) 肌萎缩侧索硬化症amyotrophic lateral sclerosis(ALS) 肌阵挛性癫伴破碎红纤维 …

[HTML][HTML] Research on the promotion of clinical practice guidelines implementation (V): evaluation of clinical guidelines implementation and expert consensus on …

HY Li, XQ Shi, J Guo, R Zhang, J Zhou, YH Jin… - New …, 2022 - yxxz.whuznhmedj.com
… implementation science into the guideline formulation process, managing and guiding
formulation from the source, and optimizing the presentation and dis-semination strategies of the …

肌萎缩侧索硬化症中NRF2 信号级联: 弥合前景与现实之间的差距

P Tarot, C Lasbleiz, JC Liévens - 中国神经再生研究(英文版), 2024 - sjzsyj.com.cn
… A potent therapeutic strategytherapy in regard to the pathophysiological mechanisms and
we provide a general overview of the attempted clinical assays in amyotrophic lateral sclerosis

超氧化物歧化酶1-肌萎缩侧索硬化症的认知障碍

I Martinelli, E Zucchi, C Simonini… - 中国神经再生研究 …, 2023 - sjzsyj.com.cn
… of how the amyotrophic lateral sclerosis phenotype responds to … the therapeutic strategy
targeting genetic mutations. Cognition in superoxide dismutase 1-amyotrophic lateral sclerosis

肌萎缩侧索硬化症患者多方面超氧化物歧化酶1 的表达: 罕见吗?

I Martinelli, J Mandrioli, A Ghezzi, E Zucchi… - 中国神经再生研究 …, 2025 - sjzsyj.com.cn
Amyotrophic lateral sclerosis (ALS) is a neuromuscular condition … mechanisms, pointing
towards a multidisciplinary approach for affected patients in light of new therapeutic strategies

肌萎縮側索硬化症生物標記與腦源性神經保護因子應用於治療神經退化性疾病之分子機轉

CS Hwang - 清華大學分子與細胞生物研究所學位論文, 2013 - airitilibrary.com
… Abstract Amyotrophic lateral sclerosis (ALS) is a complicate and progressive onset
devastating neurodegenerative disease. According to the announcement of World Health …

氧化应激-多种疾病的最低共同点

V Matschke, C Theiss, J Matschke - 中国神经再生研究(英文版), 2019 - sjzsyj.com.cn
… , as in the case of amyotrophic lateral sclerosis, or cells develop metabolic mechanisms to use
this … would allow the development of novel treatment strategies for various diseases. Thus, …

Valproic acid 在多麩醯胺擴增細胞及動物模式之療效評估

HH Wang - 臺灣師範大學生命科學研究所學位論文, 2006 - airitilibrary.com
… 方式在漸凍症(Amyotrophic lateral sclerosis) 疾病模式小鼠做… therapeutic strategy designing
in the future clinical application and reveal more implication about the molecular mechanisms

XIX 型胶原蛋白, 一种来自基底膜的有希望的生物标志物

AC Calvo, L Moreno, L Moreno, JM Toivonen… - 中国神经再生研究 …, 2020 - sjzsyj.com.cn
… experience in the field of type XIX collagen related to amyotrophic lateral sclerosis (ALS), …
collagen in ALS could facilitate novel therapeutic strategies focused on the maintenance of the …

对利鲁唑作用机制的再思考: 蛋白激酶CK1δ 活性, TDP-43 磷酸化和ALS 药理学治疗之间的分子联系

M Bissaro, S Moro - 中国神经再生研究(英文版), 2019 - sjzsyj.com.cn
… Rethinking to riluzole mechanism of action: the molecular … , and amyotrophic lateral sclerosis
pharmacological treatment … new and more effective therapeutic strategies to counter these …